376900 — Rokit Healthcare Share Price
- KR₩240bn
- KR₩287bn
- KR₩13bn
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 17.73 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | -38.78% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | KR₩m | n/a | 6,740.67 | 9,150.88 | 12,417.57 | 13,111.24 | n/a | n/a | 24.83% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | +809.65 | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Rokit Healthcare Inc is a Korea-based company primarily engaged in the development and sale of medical supplies and pharmaceutical products. The Company mainly provides three services based on the artificial intelligence (AI) organ regeneration platform. The medical 3-dimensional (3D) bioprinting service mainly manufactures 3D structures using biocompatible materials or biomaterials. The AI automated precision modeling service mainly uses AI to perform automated precision modeling of affected areas. The disposable medical device kit service provides sterile disposable medical device kits that can be assembled and disassembled directly. In addition, the Company engages in the manufacturing, development, sales, wholesale and retail, and import/export business of medical devices.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- January 20th, 2012
- Public Since
- May 12th, 2025
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
Korea Exchange - KOSDAQ
- Shares in Issue
- 15,372,639

- Address
- 12F, 9, Digital-ro 10-gil, Geumcheon-gu, SEOUL, 08514
- Web
- https://rokithealthcare.com/
- Phone
- +82 218997296
- Auditors
- Deloitte Anjin LLC
Upcoming Events for 376900
Similar to 376900
3Billion
Korea Exchange - KOSDAQ
ABion
Korea Exchange - KOSDAQ
ABL Bio
Korea Exchange - KOSDAQ
Amicogen
Korea Exchange - KOSDAQ
AprilBio Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 22:58 UTC, shares in Rokit Healthcare are trading at KR₩15,590. This share price information is delayed by 15 minutes.
Shares in Rokit Healthcare last closed at KR₩15,590 and the price had moved by over the past 365 days. In terms of relative price strength the Rokit Healthcare share price has matched the FTSE Developed Asia Pacific Index by over the past year.
There is no consensus recommendation for this security.
Find out moreRokit Healthcare does not currently pay a dividend.
Rokit Healthcare does not currently pay a dividend.
Rokit Healthcare does not currently pay a dividend.
To buy shares in Rokit Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩15,590, shares in Rokit Healthcare had a market capitalisation of KR₩240bn.
Here are the trading details for Rokit Healthcare:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 376900
Based on an overall assessment of its quality, value and momentum Rokit Healthcare is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Rokit Healthcare. Over the past six months, its share price has matched the FTSE Developed Asia Pacific Index by .
As of the last closing price of KR₩15,590, shares in Rokit Healthcare were trading -5.93% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Rokit Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩15,590.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Rokit Healthcare's directors